During the doctoral studies and in the subsequent years, her main field of interest has been the study of molecular mechanisms involved in the pathogenesis of chronic inflammatory bowel diseases, including the involvement of specific bacteria and the influence of the intestinal microbiota in the gut-liver-brain axis to identify new molecular markers as potential diagnostic and therapeutic targets. Additionally, she has been involved in the study of new therapeutic strategies based on the use of electromagnetic fields and non-pharmacological compounds as therapeutic adjuvants. In particular, the anti-inflammatory effects of probiotics and extracts of natural origin used individually, in combination, and following fermentative growth have been examined. Currently, her field of interest lies in agro-food microbiology and biotechnologies related to sustainability, quality, and safety of products and processes.